Biopharmaceuticals, an Industrial Perspective by G. WalshBiopharmaceuticals, an Industrial Perspective by G. Walsh

Biopharmaceuticals, an Industrial Perspective

EditorG. Walsh

Paperback | December 15, 2010

Pricing and Purchase Info

$417.44 online 
$440.95 list price save 5%
Earn 2087 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

This book provides a unique and up-to-date insight into the biopharmaceutical industry. Largely written by industrial authors, its scope is multidisciplinary, rendering it an ideal reference source for students undertaking advanced undergraduate or postgraduate courses in biotechnology, pharmaceutical science, biochemistry, or medicine.
Title:Biopharmaceuticals, an Industrial PerspectiveFormat:PaperbackDimensions:524 pages, 9.45 × 6.3 × 0 inPublished:December 15, 2010Publisher:Springer NetherlandsLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9048152372

ISBN - 13:9789048152377

Look for similar items by category:

Customer Reviews of Biopharmaceuticals, an Industrial Perspective

Reviews

Table of Contents

Contributors. Acknowledgements. Preface. Biopharmaceuticals, an overview; G. Walsh. Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist; R.E. Jordan, et al. Recombinant Coagulation Factor IX (BeneFix®); J. Edwards, N. Kirby. Biopharmaceutical Drug Development: A Case History; M. Foote, T. Boone. Follitropin beta (Puregon); H.J. Out. Insulin Lispro (Humalog); R.E. Chance, et al. Interferon beta-1b - the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS); R. Horowski, et al. Reteplase, a recombinant Plasminogen activator; M. Waller, U. Kohnert. Stabilisation of biopharmaceutical products and finished product formulations; M.S. Hora, B.-L. Chen. Patent Law for Biopharmaceuticals; R.S. Crespi. The development of new medicines: an overview; J.C. Stinson. The EMEA and regulatory control of (bio)pharmaceuticals within the European Union; G. Walsh. Biopharmaceutical Validation: an overview; S. Slater. Validation of Biopharmaceutical Chromatography Systems; K.F. Williams, C.J.A. Davids. Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture; P. Baker, W. Allan. Information retrieval and the biopharmaceutical industry: an introductory overview; P. O'Donnell. Information technology and the internet as a resource of biopharmaceutical information; J.P. Jenuth, et al. Marketing Issues for the (Bio)pharmaceutical sector; S. Spinka. Viral mediated gene therapy; B. Murphy. Pharmaceutical gene medicines for non-viral gene therapy; A. Rolland, et al. Index.